InvestorsHub Logo
Followers 4
Posts 625
Boards Moderated 0
Alias Born 03/08/2004

Re: None

Tuesday, 02/28/2006 1:09:18 PM

Tuesday, February 28, 2006 1:09:18 PM

Post# of 14825
31 days to go for the 10K and CC. A new Calypte has emerged, having shed the Legacy business and the overhead connected with it. The numbers for Incidence and Rapids in the 10K can be used in the future as benchmarks for determining sales performance.
If China gives approval this month (90 days from December 27th) it might take another 90 to 120 days before Calypte gets a purchase order, which takes us to June or July. I'm hopeful sales will be significantly improved by the fourth quarter. Any additional sales in 2006 from other countries will be important especially in Africa where PEPFAR money is allocated. This year is pivotal for the success of Calypte. What happens next month will determine when sales occur in China. If it's delayed I can't see making it without some type of long term financing.
It's been a long haul but (I'm finding out) that's not unusual for this type of business. Orasure in 1998 predicted sales from OraQuick by 2000; it wasn't until November 7, 2002 that the FDA gave its approval for sale. Finally, three years later they showed a profit for the first time. Orasure’s overhead is much higher than Calypte’s so I’m expecting it to be quicker for us. Hope I’m right.

sower

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.